Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.579
-0.072 (-11.00%)
At close: Nov 4, 2024, 4:00 PM
0.570
-0.009 (-1.47%)
After-hours: Nov 4, 2024, 7:59 PM EST
Ensysce Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Ensysce Biosciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ENSC.
Recommendation Trends
Rating | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +1,110.03% | Sep 25, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +1,455.75% | Jul 3, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $960 → $96 | Strong Buy | Maintains | $960 → $96 | +16,494.64% | Nov 17, 2022 |
Lake Street | Lake Street | Strong Buy Initiates $960 | Strong Buy | Initiates | $960 | +165,846.41% | Nov 30, 2021 |
Financial Forecast
Revenue This Year
1.07M
from 2.23M
Decreased by -51.98%
Revenue Next Year
n/a
from 1.07M
EPS This Year
-1.46
from -4.69
EPS Next Year
-0.93
from -1.46
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 1.3M | n/a | 84.0M | |
Avg | 1.1M | n/a | 47.8M | |
Low | 882,000 | n/a | 13.4M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -43.5% | - | - | |
Avg | -52.0% | - | - | |
Low | -60.5% | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.17 | -0.70 | 4.84 |
Avg | -1.46 | -0.93 | 4.70 |
Low | -1.71 | -1.14 | 4.52 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.